-
Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study
Mar 10, 2025, 14:00 PM -
JAV-RARAS: Analysis of Adherence to Clinical Protocols and Therapeutic Guidelines (PCDT) for Rare Diseases – A Comparison of Real-World Clinical Practice in the Context of the Value-Based Care Journey for RARAS.
Mar 10, 2025, 14:00 PM -
Optimized Treatment Sequences for ALK+ Stage IV NSCLC: Cost-Effectiveness Analysis From RCT data and Real-World Evidence
Mar 10, 2025, 14:00 PM -
How Disease Modifying Therapy Utilization In Multiple Sclerosis Is Influenced by Insurance and Out-Of-Pocket Cost in US Adults: A Summary Of Recent Literature
Mar 10, 2025, 14:00 PM -
Presenteeism in Employees with Chronic Conditions: An Analysis Using Linked Claims and Self-Reported Employee Health Risk Assessment Data
Mar 10, 2025, 14:00 PM -
Clinical and Economic Benefits of Branched Endovascular Stent Grafting for Intact Thoracoabdominal Aortic Aneurysm Repair: A Real-World Data Analysis
Mar 10, 2025, 14:00 PM -
Consumption and Expenditure of WHO Essential Medicines for Cancer: Drug Utilization Analysis of 40 Countries and Regions from 2012 to 2022
Mar 10, 2025, 14:00 PM -
Transfusion Needs For Patients With Myelofibrosis In Latin America
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Single-Inhaler Extrafine Beclometasone Dipropionate/formoterol fumarate/glycopyrronium (Trimbow®) in Adult Patients with Uncontrolled Asthma in Mexico
Mar 10, 2025, 14:00 PM -
Navigating the IRA: Impact of Medicare Part B Rebates on Drug Pricing and Manufacturer Strategies
Mar 10, 2025, 14:00 PM -
Exploring the Health and Well-being of Pediatric Caregivers within Chinese Cultural Contexts: A Systematic Review of Qualitative Studies from Chinese Databases
Mar 10, 2025, 14:00 PM -
Racial and Ethnic Disparities in Orphan Drug Utilization Among Medicare Beneficiaries
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
Outcomes Measured in Multiple Myeloma Trials in the Past 10 Years: Focus on Minimal Residual Disease and Therapy Response
Mar 10, 2025, 14:00 PM -
Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil
Mar 10, 2025, 14:00 PM -
Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis
Mar 10, 2025, 14:00 PM -
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Importance of Virtual Access for Mental Health Services: Evidence from ESI Population
Mar 10, 2025, 14:00 PM -
The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease
Mar 10, 2025, 14:00 PM -
Understanding Racial Differences in Emergency Room Visits for Patients with Lupus
Mar 10, 2025, 14:00 PM